- Home
- PHH vs RCKT Comparison
PHH vs RCKT Comparison
Compare PHH & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHH
- RCKT
- Stock Information
- Founded
- PHH 2016
- RCKT 1999
- Country
- PHH China
- RCKT United States
- Employees
- PHH N/A
- RCKT N/A
- Industry
- PHH Package Goods/Cosmetics
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- PHH Consumer Discretionary
- RCKT Health Care
- Exchange
- PHH Nasdaq
- RCKT Nasdaq
- Market Cap
- PHH 363.4M
- RCKT 326.4M
- IPO Year
- PHH 2024
- RCKT N/A
- Fundamental
- Price
- PHH $26.57
- RCKT $2.70
- Analyst Decision
- PHH
- RCKT Buy
- Analyst Count
- PHH 0
- RCKT 13
- Target Price
- PHH N/A
- RCKT $18.50
- AVG Volume (30 Days)
- PHH 420.8K
- RCKT 8.4M
- Earning Date
- PHH 01-01-0001
- RCKT 08-04-2025
- Dividend Yield
- PHH N/A
- RCKT N/A
- EPS Growth
- PHH N/A
- RCKT N/A
- EPS
- PHH 0.02
- RCKT N/A
- Revenue
- PHH $2,381,851.00
- RCKT N/A
- Revenue This Year
- PHH N/A
- RCKT N/A
- Revenue Next Year
- PHH N/A
- RCKT N/A
- P/E Ratio
- PHH $1,464.32
- RCKT N/A
- Revenue Growth
- PHH N/A
- RCKT N/A
- 52 Week Low
- PHH $3.70
- RCKT $2.19
- 52 Week High
- PHH $26.60
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- PHH N/A
- RCKT 32.09
- Support Level
- PHH N/A
- RCKT $2.66
- Resistance Level
- PHH N/A
- RCKT $3.33
- Average True Range (ATR)
- PHH 0.00
- RCKT 0.28
- MACD
- PHH 0.00
- RCKT 0.09
- Stochastic Oscillator
- PHH 0.00
- RCKT 26.59
About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.